A new chip model studies how gut microbes affect cartilage
Researchers developed a microbe-gut-cartilage axis-on-a-chip to study osteoarthritis.
Scientists developed a microbe-gut-cartilage axis-on-a-chip (MGCAoC). This device recreates tissue-specific microenvironments. It uses oxygen gradients and physiological fluid shear.
The chip design uses computer simulation optimization. It creates an anoxic-oxic interface for the gut module. This allows probiotic metabolites to reach human cartilage organoids without cross-contamination.
Multiomics profiling suggested probiotic metabolites may promote cartilage anabolism. This effect may involve PI3K and MAPK pathways. It was associated with up-regulated collagen type II and aggrecan expression. It also suppressed metalloproteinases.
In inflamed cartilage organoids, these metabolites were associated with reduced proinflammatory signaling. They also preserved matrix integrity. These chondroprotective effects were confirmed using cartilage organoids derived from patients with osteoarthritis (OA).
Studying the microbe-gut-joint axis is challenging. This is due to limitations in animal models and conventional in vitro systems. The MGCAoC provides a versatile preclinical tool for screening probiotic-based OA therapeutics.
Key facts
- The MGCAoC recreates tissue-specific microenvironments with oxygen gradients.
- Probiotic metabolites may promote cartilage anabolism through PI3K and MAPK pathways.
- The chip allows for the study of the microbe-gut-cartilage axis.